Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Potvin D, DiLiberti CE, Hauck WW, Parr AF, Schuirmann DJ, Smith RA. Sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat. 2008;7:245–62.
2. Montague TH, Potvin D, Diliberti CE, Hauck WW, Parr AF, Schuirmann DJ. Additional results for sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat. 2012;11:8–13. doi: 10.1002/pst.483 .
3. Committee for Human Medicinal Products. Investigation of Bioequivalence. European Medicines Agency, 2010. Available via http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500070039
4. Steering Committee (International Conference of Harmonization). Statistical Principles for Clinical Trials. International Conference of Harmonization. 1998. Available via http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf
5. Karalis V, Macheras P. An insight into the properties of a two-stage design in bioequivalence studies. Pharm Res. 2013;30:1824–35.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献